EPIX - ESSA Pharma Inc.
0.2012
-0.004 -1.889%
Share volume: 5,945,141
Last Updated: 10-08-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.20
0.00
-0.02%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 02-11-2025 | 05-14-2024 | 08-05-2024 | 02-11-2025 | 02-11-2025 | 05-08-2025 | 08-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 7.595 M | 10.493 M | 8.638 M | 7.695 M | 9.685 M | 7.382 M | 4.897 M | |
| Selling general and admin | 2.218 M | 4.316 M | 3.174 M | 3.507 M | 4.211 M | 3.897 M | 5.429 M | |
| Research and development | 5.377 M | 6.178 M | 5.464 M | 4.188 M | 5.474 M | 3.484 M | -531.441 K | |
| Total expenses | 7.595 M | 10.493 M | 8.638 M | 7.695 M | 9.685 M | 7.382 M | 5.042 M | |
| 38.17% | -17.68% | -10.93% | 25.87% | -23.78% | -31.69% | |||
| Operating income | -7.595 M | -10.493 M | -8.638 M | -7.695 M | -9.685 M | -7.382 M | -5.042 M | |
| Ebit | -7.603 M | -10.479 M | -8.642 M | -7.693 M | -9.678 M | -7.384 M | -5.035 M | |
| Pretax income | 0.000 | -8.990 M | -7.234 M | -12.320 M | 0.000 | 0.000 | 0.000 | |
| inf% | -19.53% | 70.31% | -100.00% | nan% | nan% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.964 M | -8.990 M | -7.234 M | -6.355 M | -8.532 M | -6.375 M | -4.003 M | |
| -50.72% | 19.53% | 12.14% | -34.25% | 25.28% | 37.20% |